0001140361-17-011280.txt : 20170309 0001140361-17-011280.hdr.sgml : 20170309 20170309190738 ACCESSION NUMBER: 0001140361-17-011280 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170307 FILED AS OF DATE: 20170309 DATE AS OF CHANGE: 20170309 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ASAR VINIT K CENTRAL INDEX KEY: 0001454324 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 17679859 MAIL ADDRESS: STREET 1: HANGER ORTHOPEDIC GROUP, INC. STREET 2: TWO BETHESDA METRO CENTER, SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 doc1.xml FORM 4 X0306 4 2017-03-07 0 0000722723 HANGER, INC. HGR 0001454324 ASAR VINIT K 10910 DOMAIN DRIVE SUITE 300 AUSTIN TX 78758 1 1 0 0 President and CEO Common Stock 2017-03-07 4 F 0 2857 13.87 D 231310 D Common Stock 2017-03-08 4 F 0 5332 13.77 D 225978 D Common Stock 2017-03-08 4 A 0 60000 0 A 285978 D Reflects payment of tax liability by withholding shares of stock incident to vesting of restricted stock previously issued. Represents a grant of time-based restricted stock under the Company's 2016 Omnibus Incentive Plan (the "Plan"), which vests to the extent of 25% annually beginning on March 8, 2018 and cumulatively vests to the extent of 25% each year thereafter. The restricted stock being reported does not include the contingent right of the reporting person to receive up to 90,000 additional performance shares under the Plan based on the achievement of certain performance targets for the fiscal year 2017. Includes (i) unvested restricted shares totaling 60,000 shares of stock from an initial grant of 60,000 shares of restricted stock that begins to vest on March 8, 2018; (ii) unvested restricted shares and fully vested shares totaling 55,897 shares of stock from an initial grant of 60,000 shares of restricted stock that begins to vest on March 7, 2017; (iii) unvested restricted shares and fully vested shares totaling 39,533 shares of stock from an initial grant of 42,390 shares of restricted stock made on March 6, 2015; (iv) unvested restricted shares and fully vested shares totaling 15,515 shares of stock from an initial grant of 17,973 shares of restricted stock made on March 7, 2014; (v) unvested restricted shares and fully vested shares totaling 23,974 shares of stock from an initial grant of 29,292 shares of restricted stock and performance shares made on March 11, 2013; [continued in next footnote] (vi) fully vested shares totaling 14,230 shares of stock from an initial grant of 17,250 shares of restricted stock and performance shares made on August 27, 2012; (vii) fully vested shares totaling 19,638 shares of stock from an initial grant of 27,600 shares of restricted stock and performance shares made on March 7, 2012; (viii) fully vested shares totaling 11,589 shares of stock from an initial grant of 15,923 shares of restricted stock and performance shares made on March 25, 2011; (ix) fully vested shares totaling 16,600 shares of stock from an initial grant of 23,000 shares of restricted stock and performance shares made on March 30, 2010; and (x) fully vested shares totaling 29,002 shares of stock from an initial grant of 42,680 shares of restricted stock and performance shares made on December 29, 2008. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Vinit K. Asar 2017-03-09